• HVE
  • Excess mortality
  • Trending
  • Calculators
    • De Covidsterfte calculator
    • With HVE from placebo to panacea

What actually depends on the ICU capacity?

by Anton Theunissen | 23 Apr 2020, 12:04

↠What do you learn from the daily RIVM updates? American whistleblowers have a point but also make mistakes →
reading time

Steering on ICU capacity

The lockdown was intended to stay within the ICU capacity and that has been successful. The ICU people have had to work their butts off and are still doing so. On the radio it was reported that they even work 200% shifts – that may have been proverbial but it does give an impression. And they are not alone. We all stand behind them in solidarity: other patients are pushed back, wards are cleared, companies go under, unemployment rises, billions evaporate so that the ICU can do its job. They work very hard and it must be all the more frustrating to see that so many of their patients do not make it.

From the perspective of care, this is only logical. After all, the ICU is - among other things - also a last resort if nothing else helps and a patient feels that he can no longer breathe. Even if he can do so but his lungs no longer extract oxygen from the air, a doctor owes it to his task and his position to get the most out of every patient. Even in almost hopeless situations, a doctor must be able to persevere, even to the point of hopeless treatments in the ICU. That is admirable and at the same time you should protect doctors from themselves. They could undoubtedly do more for more patients.

For a few weeks now, we have been seeing more or less what that overcrowded ICU has meant so far. Thanks to the ICU, the mortality rate from corona has been reduced by one-tenth of a percent: 0.1%. That means: 1 in 1000 corona-infected people has been saved by the ICU. The RIVM does not have exact figures - we are used to that by now - but according to them it is something like 1.4% instead of 1.5% mortality among corona patients, around and near. Or 1.1% instead of 1.2%. So that is an effect. Can we also look at how that effect relates to the efforts? It's almost sacrilege, but I'll take the risk anyway.

The success rate of ICU treatment in numbers

The mortality rate of corona patients in the ICU is sometimes estimated at 20%. Unfortunately, for corona patients, this fluctuates between 65%-70%. So the survival rate is about 1 in 3.

In Italy, the results were even worse. There they also admitted patients with no chance than in the Netherlands. The horror images we have seen could have been prevented if an age limit (and/or later: a BMI limit) had been used. If Italy had used stricter guidelines, promising patients who have now died in the corridor would still have had a chance. In Italy it was more of a glorified hospice. They didn't have the capacity for that.

The Netherlands, April 22

[28-4: numbers are higher, key point still valid]

In the past 6 weeks, 2680 ICU patients have been admitted [28-4: 2773]. Of these, 965 were still in the ICU on 22 April [28-4: 788]. Of the remaining 1715 ex-ICU patients [28-4: 1985], 572 [28-4: 625] came out of the ICU alive* (indeed: 33%). The data comes from the Dutch Intensive Care Evaluation Foundation. It is not known how many of these patients die later.

The blue line indicates that fewer people leave the hospital alive than come out of the ICU alive. But the delay also plays a role here and we also do not know how long ICU patients stay in hospital on average. So because of (again) the incompleteness of the data, we leave this out of consideration.

Source (dated 22 April): National Intensive Care Evaluation

There are about 550,000 people infected with the virus. (source dated April 16: Sanquin Hotels) Hence, the 572 ICU patients rescued represent 0.1% of mortality among infected people. The assumption is that the ICU survivors would not have made it without ICU, so that, for example, (home) treatment with medication and oxygen would not have helped.

I will leave aside the possibility that the ventilator has worsened the condition of many patients. There are indications of that, but that is all there is to it at the moment.

Conclusion

As a non-physician and non-economist, I would like to hear that the treatment contributes to public health and is affordable in accordance with the current standards or perhaps 2x the current standards. My main reason for writing this piece is that considerations such as these seem to be ignored.

This relativization may read like a direct attack on everything that has to do with IC. This is emphatically not the intention. What is intended: the policy focus on the ICU and what is thrown into the fight for it requires an ongoing evaluation of our targets, our performance and the ROI in terms of public health and well-being. I have not yet seen any trace of an evaluation.

An even sharper thought experiment: suppose a pharmaceutical company would come up with a corona drug, 'FiniCor'...

NEW! FINICOR!
The cure that has been proven to put an end to all your corona complaints!

  • Is no corona treatment working? Then you are automatically eligible for the Finicor cure!
  • FiniCor is only provided to patients who continue to deteriorate in the hospital despite medical care. Finicor has been proven effective in 33% of these patients. Those for whom the drug does not work (about two-thirds) will unfortunately still die.
  • The cure lasts about 3 weeks. After treatment with FiniCor, an intensive rehabilitation period is desired. This can sometimes last up to 2 years.
  • The production capacity for FiniCor is limited. In order to meet demand, the country will have to go into lockdown. This limits the rate of immunization so that supplies can be spread over a longer period of time.

Would this drug come on the market?

Money is not just 'money'. It also stands for culture and care.

Then also a financial consideration: the billions that are being invested now will later mainly be at the expense of public services such as culture and health care. Health care is perhaps the most important of these (I say as a music maker).Shortages in healthcare budgets will be at the expense of public health. I myself have Not the expertise to calculate how every billion less translates into disease and death. 'Poverty kills', the figures show that, but that's all I know. However, the scenario in which the healthcare system itself has to be put on a ventilator is not so difficult to imagine.

So I would like to see a discussion about when we are going to make difficult decisions, now or in the future when the money runs out? At the moment we still have options, but then, after the crisis, we are faced with a fait accompli that may cost many more lives than we have saved. Then we have 'Regret afterwards for what we have now left behind', to speak with Rutte.

*Living from the ICU: In addition, a minority of survivors are back on their feet after a few months. The majority are not in good shape with permanent lung damage and/or psychological trauma. No one is surprised by a two-year rehabilitation. By no means all ex-ICU patients can resume their former lives afterwards.

↠previous post Next post →
Related reading pleasure:
Managing ICU capacity: why was that? Ron Fouchier and the Safety Board keep us safe Opschalen van een grafiek scheelt 400 IC-bedden

amnesty Anne Frank antibiotics baby's Bioweapons ethics

heart failure itb we can query life expectancy Mass formation motive qaly

Spike VE WOO Bulgaria conspiracy theory Causes

John Ukraine PeterSweden RKI deferred care asmr

censorship data effectiveness iq Parliamentary inquiry rivm

UK Baseline Burkhardt journalism nocebo Excess mortality debate

alijst IC NRC Government information responsibility narrative

praise Wuhan Measures norm mortality ivermectin mdhaero

manipulation society research politics CBS lableak disinformation

communication science vaccination excess mortality statistics media

science corruption aerosols scientific integrity infection Side effects hve

Public health Children women Level Wynia Vaccination readiness

paradogma Australia Pfizer OUR Badbatches Fauci

Post-Covid opinion lockdowns filosofie foreign country Wob

sociology placebo obfuscation Gupta Germany ChatGPT

cardiovascular vitaminD Mortality Monitor privacy Repopulation Koopmans

Japan Deltavax calculator pregnancy safety thrombosis

Lawsuits Un face masks long covid Lareb Hotels ionization

fraud variegated bhakdi monkeypox Anti-VAX fear

Views (inst:8-10-'21): 464
↠What do you learn from the daily RIVM updates? American whistleblowers have a point but also make mistakes →

Would you like a notification e-mail with each new article?

Thanks for your interest!
Some fields are missing or incorrect!
Bijdragen aan virusvaria mag. Klik en vul zelf het bedrag in
👇
Contribute something? Please! Click here.
ðŸ‘

Face masks revisited

nov 21, 2025

Wrong models

nov 17, 2025

Important update in The Telegraph. Hello Keulemans?

nov 16, 2025

Data camouflage in NL and UK: Deltavax in two languages

nov 15, 2025

2024 compared to 2019 in age cohorts M/F

nov 2, 2025

Post-war birth waves and mortality expectations: the gray buffer of death

Oct 27, 2025

Mortality in the Netherlands per 100K in 5 years of cohorts (graphs) and Why Standard Mortality?

Oct 22, 2025

The curse of the sewer ghost deciphered: how excess mortality ended up as Covid mortality

Oct 15, 2025

Pension: an economic explanation for the rejection of the Mortality Standard

Oct 10, 2025

RIVM emphasizes the need for standard mortality model

Oct 5, 2025

The New World with Marlies Dekkers and Maarten Keulemans (Reaction)

sep 24, 2025

COVID vaccines: Costs and benefits in years of life

sep 21, 2025

« Previous Page

Contribute something? Please! Click here.

Translation


© Contact Anton Theunissen
We use a cookie bar on our website to inform you that we analyze the use. We do not use cookies for marketing purposes. (Google respects the privacy laws.)
OK
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDuurBeschrijving
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
Save & Accept
Aangedreven door CookieYes Logo